Schedule 13G ownership disclosure
INTRA-CELLULAR THERAPIES INC
COMMON STOCK · CUSIP: 46116X101
Event date: 2025-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 2,695,006.77 · Class: 2.5%
- Abigail P. Johnson
Shares: 2,695,006.77 · Class: 2.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-000427
- Form type
- SCHEDULE 13G/A
- Filer
- FMR LLC
- CIK
- CIK 315066
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership